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Abstract
Cystic fibrosis (CF) patients often have reduced mass and strength of skeletal muscles, including the diaphragm, the primary
muscle of respiration. Here we show that lack of the CF transmembrane conductance regulator (CFTR) plays an intrinsic role
in skeletal muscle atrophy and dysfunction. In normal murine and human skeletal muscle, CFTR is expressed and co-
localized with sarcoplasmic reticulum-associated proteins. CFTR–deficient myotubes exhibit augmented levels of
intracellular calcium after KCl-induced depolarization, and exposure to an inflammatory milieu induces excessive NF-kB
translocation and cytokine/chemokine gene upregulation. To determine the effects of an inflammatory environment in vivo,
sustained pulmonary infection with Pseudomonas aeruginosa was produced, and under these conditions diaphragmatic
force-generating capacity is selectively reduced in Cftr
2/2 mice. This is associated with exaggerated pro-inflammatory
cytokine expression as well as upregulation of the E3 ubiquitin ligases (MuRF1 and atrogin-1) involved in muscle atrophy.
We conclude that an intrinsic alteration of function is linked to the absence of CFTR from skeletal muscle, leading to
dysregulated calcium homeostasis, augmented inflammatory/atrophic gene expression signatures, and increased
diaphragmatic weakness during pulmonary infection. These findings reveal a previously unrecognized role for CFTR in
skeletal muscle function that may have major implications for the pathogenesis of cachexia and respiratory muscle pump
failure in CF patients.
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Introduction
Cystic fibrosis (CF) is caused by defects in the gene encoding the
cystic fibrosis transmembrane conductance regulator (CFTR) [1].
Despite improvements in therapy, a progressive loss of lung
function, associated with recurrent pulmonary infections and
inflammation, still prevails. Over time, the diaphragm and other
respiratory muscles become unable to sustain the increased
breathing requirement, thereby leading to respiratory failure.
This ultimately fatal situation is favored by the presence of
generalized skeletal muscle atrophy (cachexia) and weakness in
many CF patients, which has been attributed to malnutrition,
mechanical disadvantage of the respiratory muscles, and other
factors [2,3].
CFTR is a member of the superfamily of ATP-binding cassette
(ABC) transporter ATPases, which functions as a cAMP-regulated
chloride (Cl
2) channel [1,4]. The actions of CFTR extend beyond
Cl
2channel function, with several other roles described in the
secretion or absorption of different ions as well as in the transport
or regulation of other macromolecules [5,6]. It is also reported that
cells with defective CFTR have a hyperinflammatory phenotype,
characterized by an excessive production of cytokines triggered by
various stimuli [7–11]. The exaggerated inflammatory response in
CFTR-defective cells has been linked to enhanced activation of the
transcription factor NF-kB [7,9–12], a central regulator of
inflammation.
Intriguingly, CFTR transcripts have been detected in rat
skeletal muscle, although no attempts were made to elucidate a
functional role [13]. However, exercise performance can be
impaired in CF patients at early stages of the disease despite
essentially normal pulmonary function and nutritional status
[14,15]. In addition, exercise limitation in CF patients appears
to differ according to the type of CFTR mutation, independent of
pulmonary function [16]. These and other observations have led
to speculation that a specific CFTR-related functional defect could
exist in the skeletal muscles of CF patients [17].
PLoS Genetics | www.plosgenetics.org 1 July 2009 | Volume 5 | Issue 7 | e1000586Inthepresentstudy,wesoughttodeterminewhetheraspecificlink
exists between CFTR and skeletal muscle function, with a particular
emphasis on the diaphragm due to its importance for survival. Our
primary objectives were two-fold: 1) to confirm the presence,
localization, and functionality of CFTR in normal skeletal muscle;
and 2) to determine whether CFTR deficiency predisposes to
diaphragmatic muscle inflammation, atrophy, or weakness. Here we
report that CFTR protein is normally found at the level of the
sarcoplasmic reticulum (SR) in skeletal muscle, where it appears to
modulateintracellularcalciumfluxes.Wealsoshowthatinthesetting
of lung infection, the diaphragms of Cftr
2/2 mice have higher levels
of pro-inflammatory gene expression, an increased induction of
cachexia-inducing components of the ubiquitin-proteasome pathway,
and a more severe impairment of force-generating capacity than
wild-type controls. Taken together, these findings point to an intrinsic
alteration of skeletal muscle function in CFTR deficiency, which is
manifested by greater cytokine expression, atrophy, and force loss
upon exposure to an inflammatory milieu. In view of the increased
pulmonary and systemic inflammation found in CF, these phenom-
ena could play a major role in promoting chronic cachexia, as well as
the development of respiratory muscle failure during acute
pulmonary infections in CF patients.
Results
Expression of CFTR in murine and human skeletal muscle
We first demonstrated CFTR mRNA expression in diaphrag-
matic and limb muscle tissues obtained from wild-type (Cftr+/+)
mice, and this was further confirmed in primary diaphragmatic
myotube cultures (see Figure 1A). As CFTR expression is classically
associated with epithelial cells, we then compared CFTR expression
in epithelial and skeletal muscle samples. Real-time PCR revealed
that CFTR mRNA levels in both human skeletal muscle tissue and
cultured muscle cells were approximately 7-fold lower than in
human nasal epithelial cell cultures (Figure 1B). Furthermore,
immunoprecipitation followed by western blot analysis confirmed
the presence of CFTR protein in human skeletal muscle tissue and
in cultured muscle cells (Figure 1C).
Confocal immunofluorescence labeling of CFTR together with
either dystrophin or inositol triphosphate receptors (IP3Rs)– markers
of the sarcolemma and sarcoplasmic reticulum (SR), respectively –
were used to localize the CFTR protein. On transverse cross-sections
of human skeletal muscle, only occasional surface membrane staining
for CFTR could be demonstrated (Figure 2A, a–c). However,
longitudinal sections showed a consistent pattern of stereotypical
periodicity that co-localized to a substantial degree with IP3R
immunostaining (Figure 2A, d–f), suggesting that CFTR is associated
with the SR. These findings were reproduced in murine skeletal
muscle (Figure 2B, d–f), and CFTR was further co-localized with
anotherSRprotein,theryanodinereceptor(RyR)(Figure2B,g–i).As
expected, no CFTR staining was observed in the muscles of Cftr2/2
mice (Figure 2B, a–c). Furthermore, in myotubes derived from Cftr+/
+ mice, co-localization of CFTR with IP3Rs was also demonstrated
(Figure 2C).
Cftr
2/2 muscle cells exhibit abnormal calcium regulation
The SR in skeletal muscle is the major source of Ca
2+ released
via both RyRs and IP3Rs following muscle cell depolarization
[18–20]. To determine whether CFTR has an influence upon this
process, cultured Cftr
+/+ and Cftr
2/2 myotubes were loaded with
the Ca
2+ probe Fura-2 and exposed to high potassium (60 mM
KCl) to induce depolarization in vitro. Immunostaining confirmed
the absence of intracellular staining for CFTR in Cftr2/2
myotubes (Figure 3A). In Cftr
+/+ myotubes, the Ca
2+ response
consisted of a rapid rise to a peak amplitude followed by a
progressive decline to a plateau level, as shown in Figure 3B (solid
line). When Cftr
+/+ myotubes were pre-treated with a small
molecule inhibitor of CFTR channel activity (CFTR-inh172),
there was a greater initial peak as well as a higher plateau value
(Figure 3B, dashed line). Quantitative analysis confirmed that the
area under the Ca
2+ versus time curve and the peak amplitude of
Ca
2+ responses were significantly greater in Cftr
+/+ myotubes
treated with the CFTR inhibitor (see Figure 4A). An identical
approach was used to compare Ca
2+ responses of Cftr
+/+ and
Cftr
2/2 myotubes. The representative tracings in Figure 3C and
group mean quantitative analyses in Figure 4B show that Cftr
2/2
myotubes responded in a very similar fashion to Cftr
+/+ myotubes
treated with CFTR-inh172. No differences were detected between
Cftr
+/+ and Cftr
2/2 myotubes with respect to their total SR Ca
2+
content (evaluated by blocking Ca
2+ re-uptake into the SR with
thapsigargin), nor were the results influenced by omission of Ca
2+
from the extracellular medium (data not shown). Furthermore, in
Cftr
2/2 muscle cells, pre-treatment with CFTR-inh172 had no
effect on Ca
2+ responses (Figure 3D).
To better understand how CFTR could interact with RyRs
and/or IP3Rs, ryanodine was used to interfere with RyR function,
whereas for IP3 pathway interference two different compounds, 2-
APB and U73122, were used as inhibitors of IP3Rs and
phospholipase C, respectively. As shown in Figure 4C, in both
Cftr
+/+ and Cftr
2/2 myotubes all of these treatments greatly
reduced the area under curve as well as the peak amplitude of the
Ca
2+ response to depolarization. However, in Cftr
+/+ myotubes the
inhibition of RyR function had more pronounced effects than
interference with the IP3 pathway. On the other hand, RyR and
IP3R blockade had equivalent impacts upon intracellular Ca
2+ in
Cftr
2/2 myotubes, providing further evidence that Ca
2+ mobili-
zation is dysregulated in CFTR-deficient muscle cells.
Cftr
2/2 muscle cells show a hyperinflammatory
phenotype in vitro
CFTR defects have been associated with a hyperinflammatory
phenotype, with IL-8 in particular having been implicated
Author Summary
Cystic fibrosis is an autosomal recessive disorder caused by
mutations of the CF transmembrane conductance regula-
tor (CFTR), which acts as a chloride channel and also
participates in the regulation of other ions and proteins. In
most CF patients, the clinical course is dominated by lung
disease and recurrent pulmonary bacterial infections. Many
CF patients also have significant skeletal muscle wasting
and weakness, and this can affect the most essential
breathing muscle, the diaphragm. Although muscle
wasting in CF has generally been attributed to factors
such as reduced physical activity and poor nutrition, our
study reveals an intrinsic defect of skeletal muscle function
caused by the lack of CFTR. Hence, we show that CFTR is
normally found in skeletal muscle fibers of humans and
mice. In CF muscle cells lacking CFTR, abnormal elevations
of calcium and inflammatory gene expression are found. In
addition, during pulmonary infections, diaphragm muscles
lacking CFTR show greater weakness and induction of
genes which cause muscle atrophy. These findings extend
our understanding of the factors leading to exercise
limitation and disability in CF and also have implications
for the pathogenesis of respiratory muscle failure in CF
patients during lung infections.
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PLoS Genetics | www.plosgenetics.org 2 July 2009 | Volume 5 | Issue 7 | e1000586Figure 1. Expression of CFTR in normal skeletal muscle. (A) CFTR transcripts in lung, tibialis anterior (TA), and diaphragm (Dia) muscle tissue
(in vivo) as well as in cultured myotubes from wild-type (Cftr
+/+) mouse diaphragms (in vitro). (B) Relative quantification of human CFTR mRNA in
skeletal muscle tissue (MT), cultured E6/E7 skeletal muscle cells (MC), and cultured epithelial cells (EC) from human nasal mucosa. (C) Western blotting
for human CFTR after immunoprecipitation (IP) of CFTR protein in human skeletal muscle tissue and cultured human muscle cells (myotubes and
myoblasts), as well as CFTR-overexpressing positive control cells (Calu3 or HEK). Note the presence of both mature (Band C) and immature (Band B)
forms of CFTR. Top Panel: lysate amounts for IP were 1000 (lanes 3–5), 2000 (lane 6), and 200 mg (lane 7). Bottom Panel: lysate amounts for IP were
3000, 1500, and 1000 mg for lanes 2–4, respectively.
doi:10.1371/journal.pgen.1000586.g001
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PLoS Genetics | www.plosgenetics.org 3 July 2009 | Volume 5 | Issue 7 | e1000586Figure 2. Confocal localization of CFTR in skeletal muscle. (A) Double labeling for CFTR and either membrane- (dystrophin) or SR- (IP3R)
associated proteins in transverse and longitudinal sections of human skeletal muscle. (B) Double labeling of CFTR and SR (IP3R or RyR) proteins in
longitudinal sections of Cftr+/+ and Cftr2/2 mouse skeletal muscle (scale bar=10 mm). (C) Triple labeling of IP3R, CFTR, and myonuclei (DAPI) in
cultured mouse myotubes.
doi:10.1371/journal.pgen.1000586.g002
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human IL-8) expression in Cftr
+/+ and Cftr
2/2 muscle cells. There
were no detectable differences between wild-type and Cftr
2/2
myotubes under basal conditions. However, after stimulation with
pro-inflammatory cytokines (TNF-a, IL-1a, IFN-c) and Pseudomo-
nas LPS, MIP-2 showed greater upregulation in Cftr
2/2
diaphragmatic myotubes. This increased responsiveness also
involved other pro-inflammatory chemokines such as MIP-1a
and RANTES, and was similarly observed in limb muscle-derived
myotubes (Figure 5A). Because many pro-inflammatory genes are
regulated by NF-kB, and since the latter has been implicated in the
hyperinflammatory phenotype of CF epithelial cells, we examined
NF-kB (p65) binding to its DNA consensus site in nuclear extracts
obtained from Cftr
+/+ and Cftr
2/2 diaphragmatic myotubes. As
Figure 3. Abnormal calcium responses in CFTR–deficient muscle cells. (A) Negative immunostaining for CFTR in Cftr
2/2 myotubes. (B)
Representative Ca
2+ responses in Cftr
+/+ myotubes, either without (control) or with (CFTR-inh) pre-treatment by CFTR-inh172. (C) Representative Ca
2+
responses in Cftr
+/+ versus Cftr
2/2 myotubes. (D) Lack of effect of CFTR-inh172 on the area under the curve or peak amplitude of Ca
2+ responses in
Cftr
2/2 myotubes.
doi:10.1371/journal.pgen.1000586.g003
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PLoS Genetics | www.plosgenetics.org 5 July 2009 | Volume 5 | Issue 7 | e1000586shown in Figure 5B, greater binding of the NF-kB p65 subunit was
observed in Cftr
2/2 diaphragm muscle cells at 10 min after
initiating stimulation. In addition, inhibition of the NF-kB
pathway by pre-treatment with the IkB kinase (IKK)-2 inhibitor
SC-514 had similar effects in downregulating MIP-1a mRNA
expression in Cftr
2/2 and Cftr
+/+ myotubes (3–4 fold reductions
for both; p,0.05, n=6 per group), but it was only effective in
doing so for MIP-2 (2.4 fold; p,0.05) and RANTES (5.8 fold;
p,0.05) in Cftr
2/2 myotubes, suggesting a greater reliance upon
this pathway in the latter. Finally, we observed that ERK1/2
MAPK, another signal transduction molecule implicated in NF-kB
activation and cytokine gene upregulation [20], also showed
greater phosphorylation following cytomix/LPS stimulation in the
Cftr
2/2 group (Figure 5C).
Exaggerated pro-inflammatory and atrophy gene
responses in vivo
To evaluate the potential relevance ofthe above findings to the in vivo
context, Cftr
2/2 mice were infected with P. aeruginosa.W eu s e dt h e
Cftr
2/2 strain (CFTR
tm1UNC) backcrossed onto the C57Bl/6 back-
ground that has been shown to develop spontaneous lung disease [21].
As has been previously reported [22,23], the pulmonary bacterial
Figure 4. Quantification and inhibition of SR–mediated calcium release. (A) Group mean data for intracellular Ca
2+ responses in Cftr
+/+
myotubes, either without (control) or with (CFTRinh) pre-treatment by CFTR-inh172. (B) Group mean data for intracellular Ca
2+ responses in Cftr
+/+
versus Cftr
2/2 myotubes. (C) Effects of inhibiting RyR or IP3R function in Cftr
+/+ (open bars) and Cftr
2/2 (filled bars) myotubes. For all experiments,
N=minimum of 30 myotubes per group. * p,0.05 versus control, { p,0.05 for ryanodine versus 2-APB and U73122.
doi:10.1371/journal.pgen.1000586.g004
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fluid were greater in infected Cftr
2/2 mice (data not shown). At 2 days
after the initiation of pulmonary infection, there was an upregulation of
pro-inflammatory gene expression within the diaphragms of both
Cftr
2/2 and Cftr
+/+ mice. However, as was the case in vitro,t h e
diaphragmatic mRNA levels of chemokines (MIP-2, MIP-1a,
RANTES) and other cytokines (TNF-a,I L - 1 b) were significantly
higher in infected Cftr
2/2 mice (Figure 6A). Therefore, the greater
vulnerability of Cftr
2/2 diaphragms to developing a hyperinflamma-
tory phenotype in vitro was also observed in vivo.
Figure 5. Hyperinflammatory phenotype of Cftr2/2 skeletal muscle cells in vitro. (A) Upper panels: Cytokine mRNA expression levels in
Cftr
+/+ versus Cftr
2/2 diaphragmatic myotubes under control conditions (CTL) and after 4 hours of stimulation (TNF-a 1 ng/ml, IL-1a 5 U/ml, IFN-c
20 U/m, LPS 1 ng/ml). N=5 per group; * p,0.05 for control versus stimulated groups, { p,0.05 for Cftr
+/+ versus Cftr
2/2. Lower panels:
Representative RNase protection assays from diaphragm (left panel) and limb muscle (right panel). (B) NFkB p65 levels in nuclear extracts (normalized
for protein) obtained from diaphragmatic myotubes in Cftr
+/+ versus Cftr
2/2 groups stimulated for the indicated time periods (0–60 min). N=4–5 per
group; * p,0.05 for Cftr
+/+ versus Cftr
2/2. (C) Western analysis of phosphorylated (pERK1/2) and total ERK1/2 MAPK in cytoplasmic lysates from Cftr
+/+
and Cftr
2/2 diaphragmatic myotubes following stimulation with cytokines+LPS. Results are representative of 2 experiments.
doi:10.1371/journal.pgen.1000586.g005
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PLoS Genetics | www.plosgenetics.org 7 July 2009 | Volume 5 | Issue 7 | e1000586Figure 6. Hyperinflammatory phenotype of Cftr
2/2 skeletal muscle in vivo. (A) Cytokine mRNA expression levels in Cftr
+/+ versus Cftr
2/2
diaphragms for uninfected (CTL) and Pseudomonas-infected (day 2) mice. N=4–5 mice per group; * p,0.05 for control versus infected mice, { p,0.05
for Cftr
+/+ versus Cftr
2/2. (B) Real-time PCR quantification of the E3 ubiquitin ligases MuRF-1 and atrogin-1 in diaphragms of control and infected
mice. * p,0.05 for Cftr
+/+ versus Cftr
2/2.
doi:10.1371/journal.pgen.1000586.g006
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wasting via the ubiquitin-proteasome system, we proceeded to
measure the diaphragmatic expression levels of two key regulators of
this proteolytic pathway in skeletal muscle, MuRF-1 and atrogin-1
[24]. Diaphragmatic expression levels of both MuRF-1 and atrogin-
1 were increased in Cftr
2/2 mice, but not in their wild-type
littermates, after pulmonary infection with P. aeruginosa (Figure 6B).
Measurements of limb muscle (soleus) weights also indicated a
significant difference between infected Cftr
2/2 and Cftr
+/+ mice
(6.4860.17 mg versus 8.2060.24 mg; p,0.0001, n=7 per group).
Therefore, these findings are consistent with a greater susceptibility
of infected Cftr
2/2 mouse skeletal muscles not only to cytokine
upregulation,butalsotoubiquitin-mediatedproteolysisandatrophy.
Altered contractile function and excessive force loss
during P. aeruginosa lung infection in diaphragms of
Cftr
2/2 mice
We initially examined whether the different KCl-evoked
responses of cultured Cftr
+/+ and Cftr
2/2 myotubes could be
ascertained in intact perfused diaphragmatic muscle fibers.
Figure 7A shows major differences in the force response profiles
of Cftr
+/+ (monophasic pattern) and Cftr
2/2 (biphasic pattern)
fibers during KCl-induced contraction. Moreover, Cftr
+/+ dia-
phragms incubated with CFTR-inh172 exhibited a biphasic
pattern similar to the Cftr
2/2 group, while CFTR-inh172 had
no effect upon Cftr
2/2 diaphragms. In addition, when diaphrag-
matic fibers from Cftr
2/2 were electrically stimulated, a significant
prolongation of relaxation and contraction were observed during
tetanic (but not single twitch) stimulation as compared to Cftr
+/+
diaphragms (Figure 7B and 7C). Taken together, these results
corroborate the abnormal responses to depolarization in Cftr
2/2
myotubes and further indicate a functional alteration in intact
skeletal muscle fibers lacking CFTR.
To determine whether the greater increases in pro-inflammatory
and atrophy gene expression in Cftr
2/2 diaphragms are associated
with exaggerated muscle weakness during pulmonary infection,
force measurements were performed on electrically stimulated
fibers. As shown in Figure 7D, lung infection had adverse effects
upon diaphragmatic force production in the Cftr
2/2 group only.
Hence at the P. aeruginosa inoculation dose of 1610
5 cfu employed,
force-generating capacity of Cftr
+/+ diaphragms remained normal,
whereas Cftr
2/2 diaphragms generated maximal force values which
were approximately one-third lower than in identically infected
Cftr
+/+ mice. Taken together, these results indicate that the pro-
inflammatory and atrophy gene expression profiles found in the
diaphragms of infected Cftr
2/2 mice are associated with a
significant impairment of contractile function, which is manifested
byprofoundweaknessofthiscriticallyimportantrespiratorymuscle.
Discussion
The results of our study demonstrate a previously unrecognized
role for CFTR in skeletal muscle physiology, and supply new
insights into a potential mechanism favoring the development of
respiratory muscle failure in CF. The main findings of our
investigation can be summarized as follows: 1) CFTR is normally
expressed at the SR of skeletal muscle fibers and is clearly
functional, as indicated by abnormal intracellular Ca
2+ and
contractile responses to depolarization in muscles with CFTR
deficiency; and 2) diaphragm muscles lacking CFTR exhibit an
exaggerated upregulation of cytokines and cachexia-inducing
factors during pulmonary infection, which is associated with a
major deterioration of diaphragmatic function.
CFTR expression and function in normal skeletal muscle
CFTR expression has been reported in both cardiac [25–27]
and smooth muscle [28]. To our knowledge, there is only one
prior report of CFTR expression in skeletal muscle, in which a
single mRNA species of 7.5 kb was demonstrated in rat skeletal
muscle, as compared to the 6.3 kb transcript found in the lung and
intestines [13]. Whereas the most common mutation (F508 delta)
in CF patients causes CFTR to be retained in the endoplasmic
reticulum of epithelial cells, our results suggest that this may be the
major location of CFTR in skeletal muscle. Although we do not
exclude a co-existent surface membrane localization, in our study
CFTR was mostly co-localized with RyRs and IP3Rs in their
characteristic cross-striated staining pattern [18]. This is reminis-
cent of ClC-4, which co-localizes at the surface membrane with
CFTR in intestinal epithelial cells [29] but was recently shown to
be highly expressed in the SR of skeletal muscle [30]. While the
specific protein motifs responsible for differential cellular localiza-
tion of the epithelial and skeletal muscle isoforms of CFTR are
unknown, the CFTR gene is known to exhibit complex patterns of
tissue-specific expression, with different transcription start sites and
alternative splicing [27,31].
In skeletal muscle, the ClC-1 Cl
2 channel at the surface
membrane plays the predominant role in maintaining the normal
resting electrical potential of the cell [32]. The normal
physiological role of SR Cl
2 channels is more ill-defined. Several
Cl
2 channels with distinct Cl
2 conductances, selectivities, and
voltage-dependencies have been characterized in SR vesicles
[33,34]. However, in most cases the specific molecular identities of
these channels have not been determined. Both Ca
2+-induced and
voltage-activated Ca
2+ release are enhanced by Cl
2 exposure,
apparently via increased activation of RyRs [33,35]. However,
Cl
2 was also shown to inhibit caffeine-induced Ca
2+ release [36],
indicating that the regulatory effects of Cl
2 channels upon SR
function are complex. One proposed function for SR Cl
2 channels
is to permit Cl
2 to act as a counter ion during high rates of Ca
2+
release and uptake from the SR [33,34], in order to restore the SR
membrane potential, and it is possible that CFTR plays a role in
this process. CFTR could also modulate SR function in a manner
which is unrelated to Cl
2 channel activity per se. For example,
CFTR mediates glutathione flux in epithelial cells [5] and thus
plays a role in controlling the redox state, which is an important
modifier of SR Ca
2+ release [37].
Dysregulated calcium homeostasis in CFTR–deficient
muscle
In the present study, we found that defective CFTR function is
associated with increased Ca
2+ mobilization in myotubes stimu-
lated by potassium-induced depolarization. These findings are
consistent with previous observations in Cftr
2/2 vascular smooth
muscle, where greater KCl-induced vasoconstriction and impaired
relaxation are found [28], as well as increased intracellular Ca
2+
and enhanced vasoconstrictor responses during exposure to
CFTR-inh172 [38]. In our study, Ca
2+ responses to depolarization
were similarly increased irrespective of whether CFTR function
was inhibited by genetic or pharmacologic methods. Our data
indicate that the SR is the primary source of this increased Ca
2+
influx, since the latter was not affected by the removal of
extracellular calcium. The fact that inhibiting the IP3-mediated
pathway with either 2-APB or U73122 (but not the RyR) led to a
decrease of Ca
2+ values to levels obtained in Cftr
+/+ myotubes
under the same conditions, suggests that the IP3R could be the
most important source of dysregulated Ca
2+ release from the SR in
CFTR-deficient muscle cells, although this remains to be
determined. In addition, experiments performed with thapsigar-
Intrinsic Role of CFTR in Skeletal Muscle
PLoS Genetics | www.plosgenetics.org 9 July 2009 | Volume 5 | Issue 7 | e1000586Figure 7. Effects of CFTR status on diaphragmatic contractile function. (A) Response of intact diaphragmatic muscle fibers to KCl-induced
depolarization in Cftr
+/+ versus Cftr
2/2 groups, under basal conditions (N=6–7 mice per group) or with CFTR- inh172 (N=4–5 mice per group) added
to the perfusate (100 mM). (B,C): Effects of CFTR deficiency on relaxation and contraction times of the diaphragm during electrical stimulation (white
bars: Cftr
+/+; red bars: Cftr
2/2). (D) Differential effects of Pseudomonas lung infection on diaphragmatic force capacity in Cftr
+/+ and Cftr
2/2 mice (N=5
mice per group). * p,0.05 for Cftr
+/+ versus Cftr
2/2.
doi:10.1371/journal.pgen.1000586.g007
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2+ re-uptake pump, did not
point to an expansion of SR Ca
2+ stores in Cftr
2/2 muscle cells as
an explanation for the greater Ca
2+ responses [39].
Inflammatory/atrophic phenotype and force loss in
CFTR–deficient muscle
Many studies have reported that CF cell lines as well as airway
epithelial cells from CF patients exhibit exaggerated cytokine
production [7,8,11]. Several possible explanations have been
proposed, including greater Ca
2+ release from the endoplasmic
reticulum [40,41]. Defective CFTR function has also been linked to
hyperactivation of the NF-kBpathway as well assignalingmolecules
such as ERK1/2 MAPK [7,9–12], which were demonstrated in the
present study. Amongst the pro-inflammatory genes showing
enhanced upregulation within CFTR-deficient skeletal muscle in
this study, all are potential targets of NF-kB, and greater binding of
the NF-kB p65 subunit was observed in Cftr
2/2 muscle cells.
There is alsoan accumulatingliterature implicating SR-mediated
Ca
2+ release, particularly from the IP3R, in the regulation of
transcription factors controlling the expression of pro-inflammatory
and other genes in normal skeletal muscle cells [42,43]. In this
regard, it was recently reported that depolarization-induced Ca
2+
transients of even brief duration can activate NF-kB in myotubes
[20]. Furthermore, this phenomenon has been linked to increased
cytokine (IL-6) gene expression in skeletal muscle cells [44].
Therefore, although not directly examined in our study, it is
plausible to speculate that the increased NF-kB activity and pro-
inflammatory gene expression patterns observed in stimulated
Cftr
2/2 muscle cells could be linked to greater Ca
2+ release from the
SR.Indeed, an analogous phenomenon ofexaggerated Ca
2+ release
from the ER leading to NF-kB activation was recently reported in
CF airway epithelial cells stimulated with IL-1b [41].
In the present study, we demonstrated two potential causes for
muscle weakness in CFTR-deficient skeletal muscles. Firstly, we
found that Cftr
2/2 mice are more prone to a loss of muscle mass
when exposed to a hyperinflammatory milieu. This is likely linked
at least in part to the observed upregulation of E3 ubiquitin ligases,
MuRF-1 and atrogin-1, which are centrally involved in protea-
somal degradation of muscle proteins atrophy [24]. Furthermore,
NF-kB activation via IKK-2/b has been directly implicated in the
induction of the ubiquitin ligases which cause muscle atrophy [24].
Secondly, even after correction for atrophy and reduced cross-
sectional area of the muscle, diaphragmatic strength (specific force)
was abnormally decreased in infected Cftr
2/2 mice. This suggests
an alteration in the intrinsic contractile properties of the muscle
above and beyond the loss of muscle mass. Recent work has
suggested that caspase- and calpain-mediated breakdown of the
contractile protein apparatus precedes protein degradation by the
ubiquitin-proteasome system in sepsis, and may thus be respon-
sible for the loss of specific force prior to atrophy [45,46]. Indeed,
the calpain system is activated by increases in intracellular Ca
2+,
and may therefore be particularly relevant to our findings [46].
Oxidative stress has also been strongly implicated in sepsis-induced
reductions of diaphragmatic specific force [47] and it is interesting
to note that Cftr
2/2 hearts are abnormally vulnerable to tissue
damage caused by ischemia-reperfusion, a classical inducer of free
radical-mediated injury [26].
Clinical implications
Patients with CF most commonly die of type II (hypercapnic)
respiratory failure, where the limiting factor is not oxygen transfer
but rather the presence of respiratory muscle pump failure. This
occurs when the load placed on the diaphragm exceeds its capacity
to deal with the increased work of breathing. In earlier phases of
the disease, the increased load may actually induce a beneficial
training effect on the respiratory muscles [3]. However, diaphrag-
matic pressure generation normalized to its muscular mass can be
reduced by as much as 40% even in clinically stable CF patients
[3]. Therefore, any factor which further compromises the
muscular strength of the diaphragm, such as an acute pulmonary
infection with P. aeruginosa, will place patients at greater risk for the
development of respiratory failure. In our study, CFTR-deficient
skeletal muscles demonstrated a pathological phenotype primarily
during exposure to an inflammatory milieu. This is likely to be
clinically relevant, since studies suggest a quasi-constant exposure
to abnormally high serum levels of inflammatory mediators in
many CF patients [48], as well as a greater systemic inflammatory
response to exercise [49].
Taken together, we believe our findings are consistent with a
scenario (see Figure 8) in which two major factors act
synergistically to favor the development of skeletal muscle
dysfunction in CF: 1) a higher ambient level of pulmonary/
systemic inflammation leading to greater exposure of the muscles
to pro-inflammatory mediators; and 2) a greater inherent
sensitivity of the muscles (related to their lack of CFTR) to the
effects of pro-inflammatory mediator exposure. This can lead, in
turn, to an exaggerated upregulation of atrophy pathways as well
as an impairment of contractile mechanisms. On the other hand,
when the level of systemic inflammation is normal or relatively low
(e.g., in non-infected Cftr
2/2 mice and CF patients with early or
mild disease), alterations in the function of CFTR-defective
skeletal are more subtle, and may only be apparent with heavy
usage such as during exercise [15].
In conclusion, the identification in this study of an intrinsic
alteration of skeletal muscle function in CFTR deficiency extends
our understanding of the factors leading to disability in CF
patients. A major implication of our study is that the excessive
levels of pulmonary and systemic inflammation found in patients
with advanced CF can potentially initiate a positive feedback loop,
in which the abnormal vulnerability of CFTR-deficient muscle to
pro-inflammatory stimulation becomes an important component
of the downward spiral leading to respiratory muscle failure. Our
data also suggest that the chronic cachexia found in non-
respiratory skeletal muscles of many CF patients could be related
to similar mechanisms, and may thus be amenable to anti-
inflammatory therapies.
Materials and Methods
Cell culture
Primary muscle cell cultures from the mouse diaphragm and
limb muscle (tibialis anterior) were established using single living
muscle fibers as previously described in detail [50]. Culture
conditions for the E6/E7 human skeletal muscle cell line were as
previously published [51]. Calu3 cells and HEK cells stably
expressing CFTR were used as positive controls for western blot/
immunoprecipitation studies.
Immunofluorescence for confocal microscopy
Standard staining procedures were applied to myotubes grown
on glass coverslips and frozen muscle tissue sections. The analysis
was performed on 3 animals from the CFTR+/+ group, 2 animals
from the CFTR2/2 group, and 3 human muscle samples (3
sections each). Primary antibodies consisted of the following: 1:100
dilution of anti-CFTR (clone 24–1, R&D Systems); 1:50 dilution of
anti-dystrophin (clone ab15277, Abcam); 1:100 dilution of anti-
IP3R (clone NR09, Calbiochem); 1:50 dilution of anti-RyR (clone
sc-13942, Santa Cruz).
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Intracellular free Ca
2+ measurements were performed in
diaphragmatic myotubes grown on coverslips using the ratiometric
probe Fura-2(5 mM), andframeswerecollectedat 2 sintervalsfora
period of 100 s. A customized system was employed for KCl
perfusion and pharmacologic reagents applied to myotubes as
follows: 10 mM CFTR-inh172 (Calbiochem) for 30 min; 2 mM
thapsigargin (Sigma) for 400 s; 100 mM ryanodine (Sigma) for
10 min; 50 mM 2-aminoethoxydiphenylborate (APB) (Calbiochem)
for 30 min; and 10 mM U73122 (Sigma) for 20 min.
RT–PCR
Murine CFTR primers contained the following sequences (59 to
39): TCTCTGCCTTGTGGGAAATC (forward), and AGTACC
CGGCATAATCCAAG (reverse); human CFTR primers consisted
of the following (59 to 39): CTACATGGAACACATACCTTCG
(forward), and GGTGATAATCACTGCATAGC (reverse);
GAPDH primer sequences (59 to 39) were: AGCAATGCCT
CCTGCACCACC (forward), and CCGGAGGGGCCATC
CACAGTC (reverse). Real-time PCR of CFTR expression was
performedwithFAST SYBR Green,and relative quantificationwas
Figure 8. Schematic representation of respiratory muscle failure in CF. A greater inherent sensitivity of CF muscle cells to pro-inflammatory
stimuli, when combined with the higher levels of pulmonary and systemic inflammation found in CF, leads to exaggerated NF-kB and cytokine
activation within diaphragmatic muscle fibers. This in turn provokes diaphragmatic wasting and weakness in CF, thus contributing to the
pathogenesis of respiratory failure.
doi:10.1371/journal.pgen.1000586.g008
Intrinsic Role of CFTR in Skeletal Muscle
PLoS Genetics | www.plosgenetics.org 12 July 2009 | Volume 5 | Issue 7 | e1000586determined using the cycle threshold method (StepOnePlus,
Applied Biosystems). Muscle Ring Finger 1 (MuRF-1) and
atrogin-1 expression were quantified according to the manufacturer
(TaqMan).
RNase protection assay
32P-labelled riboprobes were synthesized using commercial
mouse multiprobe kits (BD Biosciences), protected RNA fragments
were separated using a 5% polyacrylamide gel, and detected by
autoradiography. Bands of individual mRNAs were quantified and
normalized to the L32 housekeeping gene (FluorChem 8000,
Alpha Innotech).
ELISA and western blot assays
An immunoassay kit was used to quantify NF-kB (p65 subunit)
within nuclear extracts, according to the manufacturer’s instruc-
tions (Trans-AM, Active Motif). To inhibit the NF-kB pathway,
myotubes were treated with the IKK-2 inhibitor SC-514
(Calbiochem) at a dose of 100 mM [52], applied one hour prior
to cytomix/LPS stimulation. Western blotting was used to evaluate
activation of ERK1/2 MAPK, using antibodies against the total
and phosphorylated forms of the protein (Cell Signaling).
CFTR protein expression was evaluated in lysates from human
skeletal muscle tissue, E6/E7 human muscle cells, Calu3 cells, and
HEK cells with stable overexpression of CFTR. CFTR was
immunoprecipitated with anti-CFTR antibody (clone M3A7) and
anti-mouse Ig beads. The precipitates were separated using an 8%
polyacrylamide gel, and then analyzed by western blotting with a
second anti-CFTR antibody (clone 23C5-2) and the TrueBlot
detection system (eBioscience).
Pseudomonas aeruginosa lung infection
Mice were infected by intratracheal inoculation at 1610
5 cfu
using a mucoid strain encapsulated within agar beads, and
euthanized at day 2 post-infection, as we have previously described
in detail [53].
Diaphragmatic contractile function
Diaphragms were mounted in an organ bath with oxygenated
Krebs solution as previously described in detail [53]. The force-
frequency relationship was determined by sequential supramaxi-
mal electrical stimulation for 1 s over a range of stimulation
frequencies. In separate experiments, diaphragmatic contraction
was induced by exposure to a modified Krebs solution containing
60 mM KCl (37uC, pH 7.40).
Animals and human materials
Animal procedures were done in accordance with the guidelines
established by the Canadian Council on Animal Care, and were
approved by the McGill University Animal Care Committee.
Pulmonary infection studies involved male mice at approximately
10 weeks of age, consisting of CFTR
tm1UNC mice and their wild-
type littermates (Cftr
2/2 and Cftr
+/+, respectively) on the C57Bl/6J
background. The Cftr
2/2 and Cftr
+/+ littermate control mice used
for generating primary muscle cell cultures were on the C57Bl/6J
or Balb/c background. All mice were generated through breeding
of heterozygous Cftr
+/2 mice maintained under specific pathogen-
free conditions at the McGill University Research Institute animal
facilities. Human muscle biopsy tissue was obtained from brain-
dead organ donors after approval by the McGill University human
ethics committee.
Statistical analysis
All data are presented as mean values6SEM. Group mean
differences were determined by Student’s t-test or analysis of variance,
with post hoc application of the Tukey test where appropriate. A
statistics software package was used for all analyses (SigmaStat 2.0,
SPSS). Statistical difference was defined as p,0.05.
Acknowledgments
The authors would like to thank Johanne Bourdon, Dusanka Gvozdic, and
Linda Yahiaoui for technical assistance; Dr. Eric Shoubridge for the
human muscle cell line; and Dr. Yves Berthiaume for human epithelial
cells.
Author Contributions
Conceived and designed the experiments: MD HB BJP. Performed the
experiments: MD HB GD ASC AD SE RR. Analyzed the data: MD HB
GD ASC AD SE BJP. Contributed reagents/materials/analysis tools: CH
RR JWH DR BJP. Wrote the paper: MD HB BJP.
References
1. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, et al. (1989)
Identification of the cystic fibrosis gene: cloning and characterization of
complementary DNA. Science 245: 1066–1073.
2. Sharma R, Florea VG, Bolger AP, Doehner W, Florea ND, et al. (2001) Wasting
as an independent predictor of mortality in patients with cystic fibrosis. Thorax
56: 746–750.
3. Pinet C, Cassart M, Scillia P, Lamotte M, Knoop C, et al. (2003) Function and
bulk of respiratory and limb muscles in patients with cystic fibrosis. Am J Respir
Crit Care Med 168: 989–994.
4. Rich DP, Anderson MP, Gregory RJ, Cheng SH, Paul S, et al. (1990)
Expression of cystic fibrosis transmembrane conductance regulator corrects
defective chloride channel regulation in cystic fibrosis airway epithelial cells.
Nature 347: 358–363.
5. Linsdell P, Hanrahan JW (1998) Glutathione permeability of CFTR.
Am J Physiol 275: C323–C326.
6. Li C, Naren AP (2005) Macromolecular complexes of cystic fibrosis
transmembrane conductance regulator and its interacting partners. Pharmacol
Ther 108: 208–223.
7. DiMango E, Ratner AJ, Bryan R, Tabibi S, Prince A (1998) Activation of NF-
kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis
respiratory epithelial cells. J Clin Invest 101: 2598–2605.
8. Kube D, Sontich U, Fletcher D, Davis PB (2001) Proinflammatory cytokine
responses to P. aeruginosa infection in human airway epithelial cell lines.
Am J Physiol Lung Cell Mol Physiol 280: L493–L502.
9. Srivastava M, Eidelman O, Zhang J, Paweletz C, Caohuy H, et al. (2004)
Digitoxin mimics gene therapy with CFTR and suppresses hypersecretion of
IL-8 from cystic fibrosis lung epithelial cells. Proc Natl Acad Sci U S A 101:
7693–7698.
10. Vij N, Fang S, Zeitlin PL (2006) Selective inhibition of endoplasmic reticulum-
associated degradation rescues DeltaF508-cystic fibrosis transmembrane regu-
lator and suppresses interleukin-8 levels: therapeutic implications. J Biol Chem
281: 17369–17378.
11. Perez A, Issler AC, Cotton CU, Kelley TJ, Verkman AS, et al. (2007) CFTR
inhibition mimics the cystic fibrosis inflammatory profile. Am J Physiol Lung
Cell Mol Physiol 292: L383–L395.
12. Weber AJ, Soong G, Bryan R, Saba S, Prince A (2001) Activation of NF-kappaB
in airway epithelial cells is dependent on CFTR trafficking and Cl- channel
function. Am J Physiol Lung Cell Mol Physiol 281: L71–L78.
13. Fiedler MA, Nemecz ZK, Shull GE (1992) Cloning and sequence analysis of rat cystic
fibrosis transmembrane conductance regulator. Am J Physiol 262: L779–L784.
14. de Meer K, Gulmans VAM, van der Laag J (1999) Peripheral muscle weakness
and exercise capacity in children with cystic fibrosis. Am J Respir Crit Care Med
159: 748–754.
15. Selvadurai HC, Allen J, Sachinwalla T, Macauley J, Blimkie CJ, et al. (2003)
Muscle function and resting energy expenditure in female athletes with cystic
fibrosis. Am J Respir Crit Care Med 168: 1476–1480.
16. Selvadurai HC, McKay KO, Blimkie CJ, Cooper PJ, Mellis CM, et al. (2002)
The relationship between genotype and exercise tolerance in children with cystic
fibrosis. Am J Respir Crit Care Med 165: 762–765.
17. Moser C, Tirakitsoontorn P, Nussbaum E, Newcomb R, Cooper DM (2000)
Muscle size and cardiorespiratory response to exercise in cystic fibrosis.
Am J Respir Crit Care Med 162: 1823–1827.
Intrinsic Role of CFTR in Skeletal Muscle
PLoS Genetics | www.plosgenetics.org 13 July 2009 | Volume 5 | Issue 7 | e100058618. Powell JA, Carrasco MA, Adams DS, Drouet B, Rios J, et al. (2001) IP(3)
receptor function and localization in myotubes: an unexplored Ca(2+) signaling
pathway in skeletal muscle. J Cell Sci 114: 3673–3683.
19. Balghi H, Sebille S, Constantin B, Patri S, Thoreau V, et al. (2006) Mini-
dystrophin expression down-regulates overactivation of G protein-mediated IP3
signaling pathway in dystrophin-deficient muscle cells. J Gen Physiol 127:
171–182.
20. Valdes JA, Hidalgo J, Galaz JL, Puentes N, Silva M, et al. (2007) NF-kappaB
activation by depolarization of skeletal muscle cells depends on ryanodine and
IP3 receptor-mediated calcium signals. Am J Physiol Cell Physiol 292:
C1960–C1970.
21. Kent G, Iles R, Bear CE, Huan L-J, Griesenbach U, et al. (1997) Lung disease in
mice with cystic fibrosis. J Clin Invest 100: 3060–3069.
22. Gosselin D, Stevenson MM, Cowley EA, Griesenbach U, Eidelman DH, et al.
(1998) Impaired ability of Cftr knockout mice to control lung infection with
Pseudomonas aeruginosa. Am J Respir Crit Care Med 157: 1253–1262.
23. van Heeckeren AM, Tscheikuna J, Walenga RW, Konstan MW, Davis PB, et al.
(2000) Effect of Pseudomonas infection on weight loss, lung mechanics, and
cytokines in mice. Am J Respir Crit Care Med 161: 271–279.
24. Cai D, Frantz JD, Tawa NE Jr, Melendez PA, Oh BC, et al. (2004) IKKbeta/
NF-kappaB activation causes severe muscle wasting in mice. Cell 119: 285–298.
25. Hart P, Warth JD, Levesque PC, Collier ML, Geary Y, et al. (1996) Cystic
fibrosis gene encodes a cAMP-dependent chloride channel in heart. Proc Natl
Acad Sci U S A 93: 6343–6348.
26. Chen H, Liu LL, Ye LL, McGuckin C, Tamowski S, et al. (2004) Targeted
inactivation of cystic fibrosis transmembrane conductance regulator chloride
channel gene prevents ischemic preconditioning in isolated mouse heart.
Circulation 110: 700–704.
27. Davies WL, Vandenberg JI, Sayeed RA, Trezise AE (2004) Cardiac expression
of the cystic fibrosis transmembrane conductance regulator involves novel exon
1 usage to produce a unique amino-terminal protein. J Biol Chem 279:
15877–15887.
28. Robert R, Norez C, Becq F (2005) Disruption of CFTR chloride channel alters
mechanical properties and cAMP-dependent Cl- transport of mouse aortic
smooth muscle cells. J Physiol 568: 483–495.
29. Mohammad-Panah R, Ackerley C, Rommens J, Choudhury M, Wang Y, et al.
(2002) The chloride channel ClC-4 co-localizes with cystic fibrosis transmem-
brane conductance regulator and may mediate chloride flux across the apical
membrane of intestinal epithelia. J Biol Chem 277: 566–574.
30. Okkenhaug H, Weylandt KH, Carmena D, Wells DJ, Higgins CF, et al. (2006)
The human ClC-4 protein, a member of the CLC chloride channel/transporter
family, is localized to the endoplasmic reticulum by its N-terminus. FASEB J 20:
2390–2392.
31. White NL, Higgins CF, Trezise AE (1998) Tissue-specific in vivo transcription
start sites of the human and murine cystic fibrosis genes. Hum Mol Genet 7:
363–369.
32. Koch MC, Steinmeyer K, Lorenz C, Ricker K, Wolf F, et al. (1992) The skeletal
muscle chloride channel in dominant and recessive human myotonia. Science
257: 797–800.
33. Sukhareva M, Morrissette J, Coronado R (1994) Mechanism of chloride-
dependent release of Ca2+ in the sarcoplasmic reticulum of rabbit skeletal
muscle. Biophys J 67: 751–765.
3 4 .K o u r i eJ I ,L a v e rD R ,J u n a n k a rP R ,G a g eP W ,D u l h u n t yA F( 1 9 9 6 )
Characteristics of two types of chloride channel in sarcoplasmic reticulum
vesicles from rabbit skeletal muscle. Biophys J 70: 202–221.
35. Fruen BR, Kane PK, Mickelson JR, Louis CF (1996) Chloride-dependent
sarcoplasmic reticulum Ca2+ release correlates with increased Ca2+ activation
of ryanodine receptors. Biophys J 71: 2522–2530.
36. Coonan JR, Lamb GD (1998) Effect of transverse-tubular chloride conductance
on excitability in skinned skeletal muscle fibres of rat and toad. J Physiol 509
(Pt 2): 551–564.
37. Sun J, Xu L, Eu JP, Stamler JS, Meissner G (2001) Classes of thiols that
influence the activity of the skeletal muscle calcium release channel. J Biol Chem
276: 15625–15630.
38. Peter BF, Lidington D, Harada A, Bolz HJ, Vogel L, et al. (2008) Role of
sphingosine-1-phosphate phosphohydrolase 1 in the regulation of resistance
artery tone. Circ Res 103: 315–324.
39. Ribeiro CM, Paradiso AM, Carew MA, Shears SB, Boucher RC (2005) Cystic
fibrosis airway epithelial Ca2+ i signaling: the mechanism for the larger agonist-
mediated Ca2+ i signals in human cystic fibrosis airway epithelia. J Biol Chem
280: 10202–10209.
40. Ribeiro CM, Paradiso AM, Schwab U, Perez-Vilar J, Jones L, et al. (2005)
Chronic airway infection/inflammation induces a Ca2+i-dependent hyperin-
flammatory response in human cystic fibrosis airway epithelia. J Biol Chem 280:
17798–17806.
41. Tabary O, Boncoeur E, de MR, Pepperkok R, Clement A, et al. (2006) Calcium-
dependent regulation of NF-(kappa)B activation in cystic fibrosis airway
epithelial cells. Cell Signal 18: 652–660.
42. Jaimovich E, Carrasco MA (2002) IP3 dependent Ca2+ signals in muscle cells
are involved in regulation of gene expression. Biol Res 35: 195–202.
43. Jaimovich E, Reyes R, Liberona JL, Powell JA (2000) IP(3) receptors, IP(3)
transients, and nucleus-associated Ca(2+) signals in cultured skeletal muscle.
Am J Physiol Cell Physiol 278: C998–C1010.
44. Juretic N, Garcia-Huidobro P, Iturrieta JA, Jaimovich E, Riveros N (2006)
Depolarization-induced slow Ca2+ transients stimulate transcription of IL-6
gene in skeletal muscle cells. Am J Physiol Cell Physiol 290: C1428–C1436.
45. Supinski GS, Ji X, Wang W, Callahan LA (2007) The extrinsic caspase pathway
modulates endotoxin-induced diaphragm contractile dysfunction. J Appl Physiol
102: 1649–1657.
46. Supinski GS, Callahan LA (2009) Calpain activation contributes to endotoxin
induced diaphragmatic dysfunction. Am J Respir Cell Mol Biol.
47. Callahan LA, Nethery D, Stofan D, DiMarco A, Supinski G (2001) Free radical-
induced contractile protein dysfunction in endotoxin-induced sepsis. Am J Respir
Cell Mol Biol 24: 210–217.
48. Elborn JS, Cordon SM, Western PJ, MacDonald IA, Shale DJ (1993) Tumour
necrosis factor-alpha, resting energy expenditure and cachexia in cystic fibrosis.
Clin Sci (Lond) 85: 563–568.
49. Ionescu AA, Mickleborough TD, Bolton CE, Lindley MR, Nixon LS, et al.
(2006) The systemic inflammatory response to exercise in adults with cystic
fibrosis. J Cyst Fibros 5: 105–112.
50. Demoule A, Divangahi M, Yahiaoui L, Danialou G, Gvozdic D, et al. (2006)
Endotoxin triggers nuclear factor-kappaB-dependent up-regulation of multiple
proinflammatory genes in the diaphragm. Am J Respir Crit Care Med 174:
646–653.
51. Lochmuller H, Johns T, Shoubridge EA (1999) Expression of the E6 and E7
genes of human papillomavirus (HPV16) extends the life span of human
myoblasts. Exp Cell Res 248: 186–193.
52. Kishore N, Sommers C, Mathialagan S, Guzova J, Yao M, et al. (2003) A
selective IKK-2 inhibitor blocks NF-kappa B-dependent gene expression in
interleukin-1 beta-stimulated synovial fibroblasts. J Biol Chem 278:
32861–32871.
53. Divangahi M, Demoule A, Danialou G, Yahiaoui L, Bao W, et al. (2007) Impact
of IL-10 on diaphragmatic cytokine expression and contractility during
Pseudomonas Infection. Am J Respir Cell Mol Biol 36: 504–512.
Intrinsic Role of CFTR in Skeletal Muscle
PLoS Genetics | www.plosgenetics.org 14 July 2009 | Volume 5 | Issue 7 | e1000586